Epilepsy Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Epilepsy Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook, and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Epilepsy Market by Condition: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Drug-Resistant

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Intractable Epilepsy

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Epilepsy Market by Diagnosis: Market Size and Forecast, 2019 – 2028  

5.1  Overview

5.2  Electroencephalography (EEG)

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.2.4   Routine EEG

5.2.5   Prolonged EEG

5.3  Radiologic Testing

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3.4   Magnetic Resonance Imaging (MRI)

5.3.5   Positron Emission Tomography (PET)

Chapter 6        Global Epilepsy Market by Geography: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.1.1   Global Epilepsy Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Condition

6.2.3.3        By Diagnosis

6.2.4   Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Condition

6.2.4.3        By Diagnosis

6.2.5   Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Condition

6.2.5.3        By Diagnosis

6.3    Europe

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   UK

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Condition

6.3.3.3        By Diagnosis

6.3.4   Russia

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Condition

6.3.4.3        By Diagnosis

6.3.5   France

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Condition

6.3.5.3        By Diagnosis

6.3.6   Italy

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Condition

6.3.6.3        By Diagnosis

6.3.7   Germany

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Condition

6.3.7.3        By Diagnosis

6.3.8   Rest of Europe

6.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.8.2        By Condition

6.3.8.3        By Diagnosis

6.4    Asia-Pacific

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   China

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Condition

6.4.3.3        By Diagnosis

6.4.4   India

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Condition

6.4.4.3        By Diagnosis

6.4.5   Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Condition

6.4.5.3        By Diagnosis

6.4.6   Rest of Asia-Pacific

6.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.6.2        By Condition

6.4.6.3        By Diagnosis

6.5    RoW

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast

6.5.3   South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Condition

6.5.3.3        By Diagnosis

6.5.4   Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Condition

6.5.4.3        By Diagnosis

6.5.5   Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Condition

6.5.5.3        By Diagnosis

Chapter 7        Company Profiles  

7.1  Abbott Laboratories.

7.1.1     Company Overview

7.1.2     Product Portfolio

7.1.3     Business Strategies

7.1.4     Financials

7.1.5     Recent Developments

7.2  Pfizer, Inc.

7.2.1     Company Overview

7.2.2     Product Portfolio

7.2.3     Business Strategies

7.2.4     Financials

7.2.5     Recent Developments

7.3  Eisai Co., Ltd.

7.3.1     Company Overview

7.3.2     Product Portfolio

7.3.3     Business Strategies

7.3.4     Financials

7.3.5     Recent Developments

7.4  Sanofi S.A.

7.4.1     Company Overview

7.4.2     Product Portfolio

7.4.3     Business Strategies

7.4.4     Financials

7.4.5     Recent Developments

7.5  GlaxoSmithKline plc.

7.5.1     Company Overview

7.5.2     Product Portfolio

7.5.3     Business Strategies

7.5.4     Financials

7.5.5     Recent Developments

7.6  Sunovion Pharmaceuticals Inc.

7.6.1     Company Overview

7.6.2     Product Portfolio

7.6.3     Business Strategies

7.6.4     Financials

7.6.5     Recent Developments

7.7  Teva Pharmaceutical Industries Ltd.

7.7.1     Company Overview

7.7.2     Product Portfolio

7.7.3     Business Strategies

7.7.4     Financials

7.7.5     Recent Developments

7.8  LivaNova PLC.

7.8.1     Company Overview

7.8.2     Product Portfolio

7.8.3     Business Strategies

7.8.4     Financials

7.8.5     Recent Developments

7.9  Others.

7.9.1     Company Overview

7.9.2     Product Portfolio

7.9.3     Business Strategies

7.9.4     Financials

7.9.5     Recent Developments